Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023/EINPresswire.com/ — Lumea, a global leader in integrated digital pathology solutions, and OptraSCAN, a leading end-to-end digital pathology solution provider, today announced a strategic commercial collaboration agreement. This agreement brings together Lumea’s comprehensive digital pathology platform with a wide range of digital scanning solutions to enable providers to ado ..read more

  Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023/EINPresswire.com/ — Lumea, a global leader in integrated digital pathology solutions, and OptraSCAN, a leading end-to-end digital pathology solution provider, today announced a strategic commercial collaboration agreement. This agreement brings together Lumea’s comprehensive digital pathology platform with a wide range of digital scanning solutions to enable providers to ado ..read more

  Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023/EINPresswire.com/ — Lumea, a global leader in integrated digital pathology solutions, and OptraSCAN, a leading end-to-end digital pathology solution provider, today announced a strategic commercial collaboration agreement. This agreement brings together Lumea’s comprehensive digital pathology platform with a wide range of digital scanning solutions to enable providers to ado ..read more

Paige and OptraSCAN have announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The two companies aim to reduce barriers to digitising glass pathology slides, which will in turn enhance workflows in pathology and oncology. Together, the companies will integrate Paige’s clinical AI applications and interoperable enterprise imaging platform with OptraSCAN’s digital pathology scanner to offer advanced end-to-end digital pathology workflow solutions. This provides a streamlined path for pathologists to ..read more

Paige and OptraSCAN have announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The two companies aim to reduce barriers to digitising glass pathology slides, which will in turn enhance workflows in pathology and oncology. Together, the companies will integrate Paige’s clinical AI applications and interoperable enterprise imaging platform with OptraSCAN’s digital pathology scanner to offer advanced end-to-end digital pathology workflow solutions. This provides a streamlined path for pathologists to ..read more

Paige on Thursday announced a partnership with OptraScan to streamline digital pathology technology adoption in the U.S., EU, and U.K. The companies aim to reduce barriers to the adoption of digitizing glass pathology slides, which will in turn enhance workflows in pathology and oncology, Paige said. “This collaboration is an important step in our mission to unlock the full potential of [artificial intelligence (AI)] in routine clinical use and provide healthcare professionals with precise insights to help patients get the most effective care,” Andy Moye, CEO of Paige, said in a statement. Ab ..read more

NEW YORK–(BUSINESS WIRE)–Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and OptraSCAN®, a leading producer of whole slide scanners, today announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The companies aim to reduce barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology and oncology. Together, the companies will integrate Paige’s clinical AI applications and interoperable enterprise imaging platform ..read more

OptraSCAN®, the leading end-to-end digital pathology solution provider announces the introduction of OnDemand Digital Pathology® solution to meet today’s need for complete digital transformation of pathology laboratories in North America. Laboratories and Hospitals can save hundreds of thousands of dollars spent on Capital purchases by subscribing to OptraSCAN OnDemand Digital Pathology® for a low monthly fee. OptraSCAN OnDemand Digital Pathology® subscription service will offer OptraSCAN whole slide digital scanners (Brightfield / Fluorescence) with 15-480 ..read more

OptraSCAN®, the leading end-to-end digital pathology solution provider announces the introduction of OnDemand Digital Pathology® solution to meet today’s need for complete digital transformation of pathology laboratories in North America. Laboratories and Hospitals can save hundreds of thousands of dollars spent on Capital purchases by subscribing to OptraSCAN OnDemand Digital Pathology® for a low monthly fee. OptraSCAN OnDemand Digital Pathology® subscription service will offer OptraSCAN whole slide digital scanners (Brightfield / Fluorescence) with 15-480 ..read more

OptraSCAN®, the leading end-to-end digital pathology solution provider announces the introduction of OnDemand Digital Pathology® solution to meet today’s need for complete digital transformation of pathology laboratories in North America. Laboratories and Hospitals can save hundreds of thousands of dollars spent on Capital purchases by subscribing to OptraSCAN OnDemand Digital Pathology® for a low monthly fee. OptraSCAN OnDemand Digital Pathology® subscription service will offer OptraSCAN whole slide digital scanners (Brightfield / Fluorescence) with 15-480 ..read more